|
IQGAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.665900E-02 |
| Normal-vs-Stage3 |
3.74550390702666E-11 |
| Normal-vs-Stage4 |
7.70200014876821E-10 |
| Stage1-vs-Stage2 |
7.414200E-04 |
| Stage1-vs-Stage3 |
4.628800E-01 |
| Stage1-vs-Stage4 |
4.279600E-01 |
| Stage2-vs-Stage3 |
8.780800E-03 |
| Stage2-vs-Stage4 |
8.212000E-04 |
| Stage3-vs-Stage4 |
2.130200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.69627999999644E-05 |
| Normal-vs-Asian |
3.65590002715521E-09 |
| Caucasian-vs-AfricanAmerican |
2.796000E-02 |
| Caucasian-vs-Asian |
4.747200E-01 |
| AfricanAmerican-vs-Asian |
1.609580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.49253959086582E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.296000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(61-80Yrs) |
9.34779999961499E-07 |
| Normal-vs-Age(81-100Yrs) |
4.695800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.412650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.616900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.414600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.097820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.778200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.544000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.204000E-02 |
| Classical-VS-Follicular |
8.88178419700125E-16 |
| Classical-VS-Other |
1.846360E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.6040949658609E-11 |
| Tall-VS-Other |
2.541900E-02 |
| Tall-VS-Normal |
5.42690337113072E-11 |
| Follicular-VS-Other |
1.517560E-01 |
| Follicular-VS-Normal |
3.786200E-01 |
| Other-VS-Normal |
1.103810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69850000730776E-09 |
| Normal-vs-N1 |
3.09850000101974E-08 |
| N0-vs-N1 |
1.317800E-02 |
|
|
